[NKTR] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 10.10%
YoY- -2.77%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 23,625 24,921 30,033 29,218 27,762 152,928 36,336 -6.92%
PBT -59,204 -129,594 -108,565 -98,486 -97,043 61,073 -43,085 5.43%
Tax -155 112 21 322 -900 202 139 -
NP -59,049 -129,706 -108,586 -98,808 -96,143 60,871 -43,224 5.33%
Tax Rate - - - - - -0.33% - -
Total Cost 82,674 154,627 138,619 128,026 123,905 92,057 79,560 0.64%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -249.94 -520.47 -361.56 -338.18 -346.31 39.80 -118.96 13.16%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.31 -0.70 -0.61 -0.56 -0.56 0.39 -0.32 -0.52%
EPS Diluted -0.31 -0.70 -0.61 -0.56 -0.56 0.37 -0.32 -0.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.